Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariette Barbier

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|February 25, 2022
Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in MiceKelly L Weaver, Catherine B Blackwood, Alexander M Horspool, et al.
Vaccine|August 4, 2022
CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in miceMegan A DeJong, M Allison Wolf, Graham J Bitzer, et al.
Frontiers in Immunology|November 12, 2019
Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From <i>Pseudomonas aeruginosa</i> Acute Murine PneumoniaEmel Sen-Kilic, Catherine B Blackwood, Dylan T Boehm, et al.
Infection and Immunity|July 17, 2024
Immunization with an mRNA DTP vaccine protects against pertussis in ratsGraham J Bitzer, Nicholas A Fitzgerald, Megan A DeJong, et al.
Infection and Immunity|February 7, 2024
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge modelsMegan A DeJong, M Allison Wolf, Graham J Bitzer, et al.
NPJ Vaccines|November 10, 2022
Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infectionsCatherine B Blackwood, Margalida Mateu-Borrás, Emel Sen-Kilic, et al.
Msphere|January 21, 2021
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 InfectionAlexander M Horspool, Theodore Kieffer, Brynnan P Russ, et al.
Frontiers in Cellular and Infection Microbiology|July 10, 2023
Monoclonal antibodies against lipopolysaccharide protect against <i>Pseudomonas aeruginosa</i> challenge in miceJason Kang, Margalida Mateu-Borrás, Hunter L Monroe, et al.
Infection and Immunity|December 15, 2020
Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in MiceM Allison Wolf, Dylan T Boehm, Megan A DeJong, et al.
Scientific Reports|May 25, 2022
EF-hand protein, EfhP, specifically binds Ca<sup>2+</sup> and mediates Ca<sup>2+</sup> regulation of virulence in a human pathogen Pseudomonas aeruginosaBiraj B Kayastha, Aya Kubo, Jacob Burch-Konda, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|February 25, 2022
Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in MiceKelly L Weaver, Catherine B Blackwood, Alexander M Horspool, et al.
Vaccine|August 4, 2022
CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in miceMegan A DeJong, M Allison Wolf, Graham J Bitzer, et al.
Frontiers in Immunology|November 12, 2019
Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From <i>Pseudomonas aeruginosa</i> Acute Murine PneumoniaEmel Sen-Kilic, Catherine B Blackwood, Dylan T Boehm, et al.
Infection and Immunity|July 17, 2024
Immunization with an mRNA DTP vaccine protects against pertussis in ratsGraham J Bitzer, Nicholas A Fitzgerald, Megan A DeJong, et al.
Infection and Immunity|February 7, 2024
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge modelsMegan A DeJong, M Allison Wolf, Graham J Bitzer, et al.
NPJ Vaccines|November 10, 2022
Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infectionsCatherine B Blackwood, Margalida Mateu-Borrás, Emel Sen-Kilic, et al.
Msphere|January 21, 2021
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 InfectionAlexander M Horspool, Theodore Kieffer, Brynnan P Russ, et al.
Frontiers in Cellular and Infection Microbiology|July 10, 2023
Monoclonal antibodies against lipopolysaccharide protect against <i>Pseudomonas aeruginosa</i> challenge in miceJason Kang, Margalida Mateu-Borrás, Hunter L Monroe, et al.
Infection and Immunity|December 15, 2020
Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in MiceM Allison Wolf, Dylan T Boehm, Megan A DeJong, et al.
Scientific Reports|May 25, 2022
EF-hand protein, EfhP, specifically binds Ca<sup>2+</sup> and mediates Ca<sup>2+</sup> regulation of virulence in a human pathogen Pseudomonas aeruginosaBiraj B Kayastha, Aya Kubo, Jacob Burch-Konda, et al.
Pageof 8